IR LIBRARY News & Press Releases 05/22 IR Correction Extraordinary Report (in Japanese) 05/14 IR Consolidated Financial Results for the Three Months Ended March 31, 2026 (under IFRS) 05/08 IR Notice Concerning Completion of Payment for Issuance of New Shares as Restricted Stock Compensation 05/08 Media Kubota Vision Announces Presentation of emixustat by Dr. Ryo Kubota at ARVO 2026: "A Phase 3 randomized trial comparing emixustat with placebo for the treatment of macular atrophy secondary to Stargardt disease." more info For information on SEC filings, please visit U.S. SEC's EDGAR service. CEO Message Company Financials SEC Filings Shareholders Meeting IR News Corporate Governance Financial Events Calendar FAQs Email Alerts
